controlElectronuchal acupuncture group treatmentSmell therapy group treatmentElectronuchal acupuncture combined with smell and inhalation therapy group treatmentSham stimulation
control: Donepezil hydrochloride was administered at 5 mg once a day (nightly) for 30 days without adverse reactions and then increased to 10 mg once a day (nightly) for 4 weeks.
Electronuchal acupuncture group treatment: Electronuchal acupuncture
Smell therapy group treatment: nasal suction intervention with volatile oil of Acorus calamus
Electronuchal acupuncture combined with smell and inhalation therapy group treatment: On the basis of electric nuchal acupuncture treatment, sniffing and inhalation therapy is given.
Sham stimulation: In the sham stimulation group, non-transdermal comfortable acupuncture will be used to make the patients experience a feeling similar to acupuncture.
Study summary
The patients with cognitive impairment after stroke were divided into control group, electroacupuncture group, olfactory therapy group, electroacupuncture combined with olfactory therapy group, and sham group with 35 people in each group. After the end of the treatment, the clinical efficacy was evaluated.
Eligibility
Sex
ALL
Min age
—
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria:
* (1) Stroke as per the TCM definition, presenting symptoms include unilateral paresis or paralysis, sensory deficits, speech impairment, and hemianopsia. PSCI diagnosis involves clinically significant deficits in at least one cognitive domain and severe disruption of instrumental ADLs/ADLs.; (2) The scores on the MMSE scale must adhere to the following criteria: Less than 17 points for individuals with illiteracy, less than 20 points for those with primary school education, and less than 24 points for individuals with a middle school education or higher.; (3) Aged under 70 years; (4) No history of mental illness, clear consciousness, stable vital signs, and able to complete the scale assessment; (5) Within 6 months post-stroke, diagnosed as a patient in the recovery period of cerebral infarction (or cerebral hemorrhage) at admission; (6) Signed informed consent by the patient or their family.
Exclusion Criteria:
* (1) Transient ischemic attack; (2) Subarachnoid hemorrhage; (3) History of severe liver or kidney diseases, mental illness, epilepsy, asthma, or obstructive pulmonary diseases; (4) Occurrence of cognitive impairment prior to stroke; (5) Severe communication barriers; (6) Substance abuse or heavy alcohol consumption; (7) Implanted cardiac pacemakers or other electronic devices.
Primary outcome measure(s)
MoCA — 0,4 weeks after the intervention, 8 weeks after the intervention Montreal Cognitive Assessment Scale
Trial sites (1)
Facility
City
Region
Status
the Affiliated Zhejiang Provincial People's Hospital to Hangzhou Medical College.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.